Seidal T[au] - Search Results

Year	Number of Results
1981	1
1982	2
1984	1
1987	1
1988	2
1989	6
1990	3
1991	2
1992	3
1993	3
1996	1
1997	1
1998	2
1999	1
2000	4
2001	5
2002	1
2004	1
2005	2
2006	2
2007	1
2008	1
2009	2
2010	2
2011	4
2012	1
2013	2
2015	2
2016	1
2017	3
2018	1
2019	1
2021	4
2022	2

1

Interpretation and quantification of immunostains.

Seidal T, Balaton AJ, Battifora H. Seidal T, et al. Am J Surg Pathol. 2001 Sep;25(9):1204-7. doi: 10.1097/00000478-200109000-00013. Am J Surg Pathol. 2001. PMID: 11688582 Review.

2

PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens: A Comparison with Biopsies and Review of the Literature.

Mansour MSI, Lindquist KE, Seidal T, Mager U, Mohlin R, Tran L, Hejny K, Holmgren B, Violidaki D, Dobra K, Dejmek A, Planck M, Brunnström H. Mansour MSI, et al. Among authors: seidal t. Acta Cytol. 2021;65(6):501-509. doi: 10.1159/000517078. Epub 2021 Jul 7. Acta Cytol. 2021. PMID: 34233336 Free PMC article. Review.

3

Rhabdomyosarcoma.

Seidal T. Seidal T. Histopathology. 1990 Nov;17(5):482-4. doi: 10.1111/j.1365-2559.1990.tb00780.x. Histopathology. 1990. PMID: 2076878 No abstract available.

4

Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma.

Mansour MSI, Seidal T, Mager U, Dobra K, Brunnström H, Dejmek A. Mansour MSI, et al. Among authors: seidal t. Cancer Cytopathol. 2021 Jun;129(6):468-478. doi: 10.1002/cncy.22401. Epub 2021 Jan 25. Cancer Cytopathol. 2021. PMID: 33493383 Free PMC article.

5

Factors Influencing Concordance of PD-L1 Expression between Biopsies and Cytological Specimens in Non-Small Cell Lung Cancer.

Mansour MSI, Hejny K, Johansson F, Mufti J, Vidis A, Mager U, Dejmek A, Seidal T, Brunnström H. Mansour MSI, et al. Among authors: seidal t. Diagnostics (Basel). 2021 Oct 18;11(10):1927. doi: 10.3390/diagnostics11101927. Diagnostics (Basel). 2021. PMID: 34679625 Free PMC article.

6

[The debate about the very late abortions is much needed].

Seidal T, Kischkel A. Seidal T, et al. Lakartidningen. 2017 Aug 28;114:ES3R. Lakartidningen. 2017. PMID: 28850166 Free article. Swedish. No abstract available.

7

Nordic immunohistochemical quality control.

Vyberg M, Torlakovic E, Seidal T, Risberg B, Helin H, Nielsen S. Vyberg M, et al. Among authors: seidal t. Croat Med J. 2005 Jun;46(3):368-71. Croat Med J. 2005. PMID: 15861513 Free article.

8

Cell Cycle Regulator p27 Mediates Body Mass Index Effects in Ovarian Cancer in FIGO-stages I-II.

Skirnisdottir I, Akerud H, Seidal T, Sundstrom-Poromaa I. Skirnisdottir I, et al. Among authors: seidal t. Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):443-450. doi: 10.21873/cgp.20148. Cancer Genomics Proteomics. 2019. PMID: 31659099 Free PMC article. Clinical Trial.

9

Determination of PD-L1 expression in effusions from mesothelioma by immuno-cytochemical staining.

Mansour MSI, Seidal T, Mager U, Baigi A, Dobra K, Dejmek A. Mansour MSI, et al. Among authors: seidal t. Cancer Cytopathol. 2017 Dec;125(12):908-917. doi: 10.1002/cncy.21917. Epub 2017 Sep 18. Cancer Cytopathol. 2017. PMID: 28922567 Free article.

10

Napsin A as a marker of clear cell ovarian carcinoma.

Skirnisdottir I, Bjersand K, Akerud H, Seidal T. Skirnisdottir I, et al. Among authors: seidal t. BMC Cancer. 2013 Nov 5;13:524. doi: 10.1186/1471-2407-13-524. BMC Cancer. 2013. PMID: 24191930 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results